Medicine & pharmacy

Frost & Sullivan Recognizes Novotech as 2025 Global Biotech CRO Company of the Year

SYDNEY–(BUSINESS WIRE)– In recognition of its innovation, client-focused delivery, and global impact, Novotech has been awarded the 2025 Global Biotechnology Contract Research Organization (CRO) Company...

Tinnitus Research: Novel Compound AC102 Makes Constant Ear Noise Disappear in Preclinical Model

ERLANGEN, Germany & BERLIN–(BUSINESS WIRE)– The novel compound AC102 almost completely reversed tinnitus in a preclinical model after a single dose. At the same time,...

Medimaps Group Launches In Europe TBS Osteo Next-Generation Software For Advanced Bone Microarchitecture Assessment

New TBS Osteo Advanced next-generation software enhances fracture risk detection beyond standard of care in osteoporosis, a silent disease affecting over 32 million Europeans1 TBS...

CroíValve Announces Funding from Horizon Europe EIC Accelerator

DUBLIN–(BUSINESS WIRE)– CroíValve, a pioneering medical device company innovating a better way to help more patients suffering from Tricuspid Regurgitation (TR), was awarded funding from...

Ferring ADAPT-1 Trial Builds on Dosing Evidence for Follitropin Delta

Data presented today at the ESHRE congress builds evidence for conventional-based Follicular Stimulating Hormone (FSH) dosing for Rekovelle® (follitropin delta); alongside its existing unique algorithm-based...

Vertex Announces European Commission Approval of ALYFTREK®, a New Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis

– ALYFTREK® (deutivacaftor/tezacaftor/vanzacaftor) approved in the EU for people with CF 6 years and older with at least one non-class I mutation in the CFTR...

Equazen® herbevestigt toewijding voor compromisloze kwaliteit en duurzaamheid in omega-voedingssupplementen

Equazen® blijft de referentie voor uitmuntendheid bepalen bij elke stap van de waardeketen. LUGANO, Zwitserland–(BUSINESS WIRE)– SFI Health™ EMEA, de regionale entiteit van SFI Health™,...

Galderma Announces Departure of Its Chief Financial Officer

Ad hoc announcement pursuant to Art. 53 LR ZUG, Switzerland–(BUSINESS WIRE)– Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that Thomas Dittrich,...

SS&C Blue Prism voor het zevende jaar op rij erkend als Gartner® Magic Quadrant™ RPA Leader

WINDSOR, Conn.–(BUSINESS WIRE)– SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) maakte vandaag bekend dat SS&C Blue Prism erkend werd als Leader in de 2025 Gartner Magic...

SBC Medical toegevoegd aan Russell 3000® Index

IRVINE, Calif.–(BUSINESS WIRE)– SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (‘SBC Medical’), een wereldwijde franchise en aanbieder van diensten aan esthetische klinieken, is toegevoegd als...

SS&C Blue Prism Recognized as a Gartner® Magic Quadrant™ RPA Leader for the Seventh Consecutive Year

WINDSOR, Conn.–(BUSINESS WIRE)– SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that SS&C Blue Prism has been recognized as a Leader in the 2025 Gartner...

Takeda Announces U.S. FDA Approval of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content1

GAMMAGARD LIQUID ERC [immune globulin infusion (human)] with Less Than or Equal to 2 µg/mL IgA in a 10% Solution is Approved for Intravenous or...

Ant Group 2024 Sustainability Report Highlights AI-Powered Digital Inclusion and New Initiatives From 3 Independent Units

HANGZHOU, China–(BUSINESS WIRE)– Ant Group today published its 2024 Sustainability Report, highlighting its enhanced AI investments in advancing broad-based digital transformation. The report also shares...

SBC Medical added to membership of Russell 3000® Index

IRVINE, Calif.–(BUSINESS WIRE)– SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, has been added...

PRD Therapeutics kondigt de aanvang aan van de eerste studie bij mensen voor PRD001

TOKIO–(BUSINESS WIRE)– PRD Therapeutics, Inc., een bedrijf actief in de klinische fase dat zich toelegt op de ontwikkeling van nieuwe regulators voor het lipidenmetabolisme gericht...